Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic …
Biotechnology
US, Cambridge [HQ]
Lobbying Analysis
Lobbying · US Senate · InfluenceHistory
Download| FY | Quarter | Expense For Lobby Disclosure | LDA Reference |
|---|---|---|---|
| 2024 | 1 | $6,000,000 | LD-2 : 04/22/24 |
| 2024 | 1 | $6,000,000 | LD-2 : 04/12/24 |
| 2023 | 4 | $5,000,000 | LD-2 : 01/19/24 |
| 2023 | 4 | $5,000,000 | LD-2 : 01/18/24 |
| 2023 | 4 | $6,000,000 | LD-2 : 01/16/24 |